Loading institutional data...
Loading institutional data...
Held by 1,250 of 5,944 reporting institutions (99th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
No trend data available for this metric.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $21.59B 100.0% | $22.02B 100.0% | $23.16B 100.0% | $36.63B 100.0% | $25.96B 100.0% | $17.81B 100.0% | $20.91B 100.0% | $17.82B 100.0% | $12.51B 100.0% | $10.09B 100.0% |
| Cost of Revenue | — | $3.12B 14.2% | $3.12B 13.5% | $3.27B 8.9% | $2.77B 10.7% | $2.41B 13.5% | $2.79B 13.3% | $2.83B 15.9% | $2.94B 23.5% | — |
| Cost of Products | — | — | — | — | — | — | — | $6.57B 36.8% | $5.59B 44.7% | $5.19B 51.4% |
| Selling, General & Admin | $986.0M 4.6% | $960.0M 4.4% | $987.0M 4.3% | $945.0M 2.6% | $863.0M 3.3% | $864.0M 4.9% | $893.0M 4.3% | $585.0M 3.3% | — | — |
| Interest Expense | $1.08B 5.0% | $1.17B 5.3% | $957.0M 4.1% | $1.03B 2.8% | $1.61B 6.2% | $1.42B 8.0% | $1.07B 5.1% | $389.0M 2.2% | $345.0M 2.8% | $292.0M 2.9% |
| Other Income (Expense), net | $76.0M 0.4% | $759.0M 3.4% | $426.0M 1.8% | $1.11B 3.0% | $753.0M 2.9% | -$53.0M -0.3% | $606.0M 2.9% | $331.0M 1.9% | $357.0M 2.9% | — |
| Pretax Income | $3.13B 14.5% | $4.02B 18.3% | $4.66B 20.1% | $14.12B 38.5% | $3.71B 14.3% | -$15.71B -88.2% | $354.0M 1.7% | $5.61B 31.5% | $1.33B 10.6% | -$1.66B -16.5% |
| Income Tax Expense | $1.02B 4.7% | $1.16B 5.3% | $1.33B 5.7% | $813.0M 2.2% | $915.0M 3.5% | -$2.17B -12.2% | $861.0M 4.1% | $1.48B 8.3% | $17.0M 0.1% | -$662.0M -6.6% |
| Net Income | $2.37B 11.0% | $3.08B 14.0% | $4.70B 20.3% | $13.30B 36.3% | $2.32B 8.9% | -$14.83B -83.3% | -$985.0M -4.7% | $4.13B 23.2% | $1.31B 10.5% | -$574.0M -5.7% |
| Per Share | ||||||||||
| EPS (Basic) | $1.65 | $2.59 | $4.22 | $13.41 | $1.62 | $-17.06 | $-1.22 | $5.40 | $1.71 | $-0.75 |
| EPS (Diluted) | $1.61 | $2.44 | $3.90 | $12.40 | $1.58 | $-17.06 | $-1.22 | $5.39 | $1.70 | $-0.75 |
| Weighted Avg Shares (Basic) | 975.5M | 911.8M | 889.2M | 926.2M | 935.0M | 918.7M | 809.5M | 761.7M | 765.1M | 763.8M |
| Weighted Avg Shares (Diluted) | 1.00B | 967.1M | 960.9M | 1.00B | 958.8M | 918.7M | 809.5M | 763.3M | 765.9M | 763.8M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
4/8 of the 9 checks — 1 couldn't be scored (see above), so the score is out of the 8 with data.
Insufficient balance-sheet detail (needs retained earnings, working capital, equity).
Needs granular two-year detail (receivables, PP&E, D&A, SG&A) — not fully reported.
Earnings are backed by cash (FCF ≥ net income) — high quality. Lower/negative accruals = higher quality (Sloan).
Coverage data unavailable.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on $4.1B FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Insufficient data. Current ROIC on all capital: 4%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $2.0B covers the $500M due within a year 3.9× over. Scheduled principal only (excludes interest & revolver draws). As of 2017-12-31 (10-K).
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest expense isn't separately reported — often netted into “other income (expense), net.” Effective rate ~5.2% on $20.6B of debt.
Cash vs short-term debt unavailable.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
No current price collected.
Where each multiple sits in its own 14-yr range
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Operating leverage needs meaningful revenue change.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 15.9 | 13.3 | 13.5 | 10.7 | 8.9 | 13.5 | 14.2 | — |
| SG&A | 3.3 | 4.3 | 4.9 | 3.3 | 2.6 | 4.3 | 4.4 | 4.6 |
| Income Tax | 8.3 | 4.1 | -12.2 | 3.5 | 2.2 | 5.7 | 5.3 | 4.7 |
| Net Income | 23.2 | -4.7 | -83.3 | 8.9 | 36.3 | 20.3 | 14.0 | 11.0 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on OXY: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.